Beta-glycoglycosphingolipid-induced augmentation of the anti-HBV immune response is associated with altered CD8 and NKT lymphocyte distribution: a novel adjuvant for HBV vaccination (Q81117567)

From Wikidata

Jump to navigation Jump to search

scientific article published on 03 April 2008

Language	Label	Description	Also known as
English	Beta-glycoglycosphingolipid-induced augmentation of the anti-HBV immune response is associated with altered CD8 and NKT lymphocyte distribution: a novel adjuvant for HBV vaccination	scientific article published on 03 April 2008

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18423947%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Beta-glycoglycosphingolipid-induced augmentation of the anti-HBV immune response is associated with altered CD8 and NKT lymphocyte distribution: a novel adjuvant for HBV vaccination (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18423947%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

immunologic adjuvant

1 reference

based on heuristic

inferred from title

author name string

Meir Mizrahi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18423947%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Gadi Lalazar

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18423947%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Ami Ben Ya'acov

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18423947%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Dan M Livovsky

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18423947%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Yuval Horowitz

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18423947%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Lidya Zolotarov

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18423947%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Ruth Adler

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18423947%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Daniel Shouval

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18423947%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Yaron Ilan

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18423947%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

3 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18423947%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18423947%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18423947%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18423947%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

2589-2595

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18423947%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Hepatitis B vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

Two decades of universal hepatitis B vaccination in taiwan: impact and implication for future strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

Immunogenicity of hepatitis B Vaccines. Implications for persons at occupational risk of hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

Hepatitis B virus immunization with an adjuvant containing vaccine after liver transplantation for hepatitis B-related disease: failure of humoral and cellular immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

Failure to respond to hepatitis B vaccine in children with celiac disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

The biology of NKT cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

The diverse functions of CD1d-restricted NKT cells and their potential for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

T-cell regulation by CD4 regulatory T cells during hepatitis B and C virus infections: facts and controversies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

Beta-glucosylceramide: a novel method for enhancement of natural killer T lymphoycte plasticity in murine models of immune-mediated disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

Alleviation of acute and chronic graft-versus-host disease in a murine model is associated with glucocerebroside-enhanced natural killer T lymphocyte plasticity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

Liver-associated lymphocytes expressing NK1.1 are essential for oral immune tolerance induction in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

Up-regulation of CD1d expression restores the immunoregulatory function of NKT cells and prevents autoimmune diabetes in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

Comparative immunogenicity of a PreS/S hepatitis B vaccine in non- and low responders to conventional vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

Depletion of CD25+CD4+T cells (Tregs) enhances the HBV-specific CD8+ T cell response primed by DNA immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

Thymosin-alpha1 increases intrahepatic NKT cells and CTLs in patients with chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

Activation and function of hepatic NK cells in hepatitis B infection: an underinvestigated innate immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

Natural killer T cell activation inhibits hepatitis B virus replication in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

The immunological function of iGb3

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

Role of Vα 14 NKT cells in the development of impaired liver regeneration in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

Activation of hepatic NKT cells and subsequent liver injury following administration of α-galactosylceramide

2 references

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

based on heuristic

inferred from DOI database lookup

Glycolipids as immune modulatory tools

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

Glucocerebroside ameliorates the metabolic syndrome in OB/OB mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

Rules of recruitment for Th1 and Th2 lymphocytes in inflamed liver: a role for alpha-4 integrin and vascular adhesion protein-1

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

Immune role of hepatic TLR-4 revealed by orthotopic mouse liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

Human liver sinusoidal endothelial cells induce apoptosis in activated T cells: a role in tolerance induction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

The 2003 ASBMB-Avanti Award in Lipids Address: Applications of novel synthetic lipids to biological problems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.03.026

7 January 2021

Identifiers

10.1016/J.VACCINE.2008.03.026

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18423947%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18423947%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q81117567&oldid=2243103428"